P312: Blood safety: how to prevent contamination by HIV, Hepatitis B and C and Syphilis to blood donor in Lubumbashi
Antimicrobial Resistance and Infection Control volume 2, Article number: P312 (2013)
Blood transfusion is an essential part of healthcare requiring equitable access to safe blood. In DR Congo, millions of patients do not have timely access to safe blood for lack of blood donors with reliable risk products contaminated with HIV, hepatitis and other chronic infections.
To study the prevalence of HIV, HBV, HCV, RPR among blood donors and answers to reduce the risk of viral transmission by blood.
A descriptive study of serum markers cross of HIV / AIDS, Hepatitis B and C and syphilis among the blood donors (volunteer and paid family) admitted to provincial blood center in the province of Katanga in 2007.
It was observed in blood donors. A seroprevalence:
6.5% for HIV among volunteers against 4.8% for family donors and 2.2% for paid donors.
3.9% for HBV among volunteers against 5.5% for the family, and 2.7% for wages.
0.45% for HCV among volunteers against 0.94% to 0.67% and the family paid for.
0.00% for the RPR among volunteers against 0.11% to 0.07% and the family paid for.
Resistance to the implementation of standards related to the transfusion'' insufficient information caregivers, blood banks and transfusion safety and quality management, as well as the disruption of health care system and the multiplicity of indications and emergencies.
Need for screening of antibodies on blood donation and transfusion safety strengthen these four infectious diseases.
Disclosure of interest
About this article
Cite this article
Wembonyama, O., Tshilolo, M., Tshintshiompo, C. et al. P312: Blood safety: how to prevent contamination by HIV, Hepatitis B and C and Syphilis to blood donor in Lubumbashi. Antimicrob Resist Infect Control 2 (Suppl 1), P312 (2013). https://doi.org/10.1186/2047-2994-2-S1-P312
- Blood Donor
- Quality Management
- Chronic Infection